Safety and Tolerability of ODM-203 in Subjects With Advanced Solid Tumours
Clinical trial NCT02264418 · COMPLETED
Trial details
- NCT number
- NCT02264418
- Sponsor
- Orion Corporation, Orion Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-18
- Primary completion
- 2019-05-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.